Investment Summary |
|
|---|---|
| Date | 2020-11-10 |
| Target | Partium |
| Sector | Software |
| Investor(s) | Anzu Partners |
| Deal Type | Venture |
SEARCH BY
| Category | Growth Capital Firm |
|---|---|
| Founded | 2014 |
| PE ASSETS | 1.0B USD |
| Size | Middle-Market |
| Type | Sector Agnostic |
Anzu Partners is a venture capital and private equity firm that looks to develop and commercialize technological advancements in manufacturing, materials, monitoring/measurement, and modeling. This includes 3D printing, robotics, nanotechnology, composites, sensors, AI, and analytics. Anzu Partners was formed in 2014 and is headquartered in Boston, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 23 of 36 |
| Sector: Software M&A | 2 of 3 |
| Type: Venture M&A Deals | 22 of 32 |
| State: Pennsylvania M&A | 2 of 3 |
| Country: United States M&A | 20 of 30 |
| Year: 2020 M&A | 9 of 9 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-09-02 |
Aspinity
Pittsburgh, Pennsylvania, United States Aspinity engages in design and development of analog machine learning chips that are revolutionizing the architecture of always-on sensing devices that run on battery. Aspinity was founded in 2015 and is based in Pittsburgh, Pennsylvania. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-02-17 |
Excision BioTherapeutics
Watertown, Massachusetts, United States Excision BioTherapeutics is a biotechnology company developing CRISPR-based therapies to cure viral infection diseases and improve the lives of chronically ill patients. Excision BioTherapeutics was founded in 2015 and is based in Watertown, Massachusetts. |
Buy | - |
